Back to search results

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Abroad (travel likely)RecruitingPHASE1

Conditions

Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Lymphocytic Leukemia · Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Hematopoietic and Lymphatic System Neoplasm · Hodgkin Lymphoma · Lymphoblastic Lymphoma · Myelodysplastic Syndrome · Myelofibrosis · Myeloproliferative Neoplasm · Non-Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Ryotaro Nakamura) · RNakamura@coh.org · 626-256-4673
    Contact: Principal Investigator (Ryotaro Nakamura)

  • Northside Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Scott R. Solomon) · ssolomon@bmtga.com · 404-255-1930
    Contact: Principal Investigator (Scott R. Solomon)

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Lindsey R. Baden) · lbaden@bwh.harvard.edu · 617-732-6801
    Contact: Principal Investigator (Lindsey R. Baden)
Study leads

  • Ryotaro Nakamura

    Principal Investigator

    City of Hope Medical Center

View source on ClinicalTrials.gov(opens in a new tab)